KALA BIO, Inc.
NASDAQ: KALA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Avi Minkowitz
- Employees
- 38
- Headquarters
- Arlington, United States
- IPO year
- 2017
- Market cap
- $65.8M
- Website
- https://www.kalarx.com
Loading KALA…
Loading profile data…Frequently asked questions about KALA
What does KALA BIO, Inc. (KALA) do?
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseas...
Where does KALA trade?
KALA BIO, Inc. (KALA) trades on the NASDAQ Global Select.
What sector is KALA in?
KALA BIO, Inc. (KALA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of KALA BIO, Inc.?
Avi Minkowitz is the chief executive officer of KALA BIO, Inc. (KALA).
Where is KALA BIO, Inc. headquartered?
KALA BIO, Inc. is headquartered in United States.
Does KALA pay a dividend?
KALA BIO, Inc. (KALA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KALA go public?
KALA BIO, Inc. (KALA) completed its initial public offering in 2017.